Shelton Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.7M | Buy |
49,244
+1,789
| +4% | +$397K | 0.23% | 97 |
|
|
2025
Q4 | $10.8M | Sell |
47,455
-3,031
| -6% | -$690K | 0.21% | 103 |
|
|
2025
Q3 | $11.7M | Buy |
50,486
+11,210
| +29% | +$2.28M | 0.25% | 98 |
|
|
2025
Q2 | $7.29M | Sell |
39,276
-11,804
| -23% | -$2.19M | 0.17% | 126 |
|
|
2025
Q1 | $10.7M | Sell |
51,080
-35,116
| -41% | -$6.83M | 0.25% | 103 |
|
|
2024
Q4 | $15.3M | Sell |
86,196
-6,784
| -7% | -$1.25M | 0.38% | 51 |
|
|
2024
Q3 | $18.4M | Sell |
92,980
-32,661
| -26% | -$6.1M | 0.47% | 37 |
|
|
2024
Q2 | $21.5M | Buy |
125,641
+7,900
| +7% | +$1.31M | 0.59% | 32 |
|
|
2024
Q1 | $21.4M | Buy |
117,741
+22,117
| +23% | +$3.81M | 0.61% | 30 |
|
|
2023
Q4 | $14.8M | Buy |
95,624
+29,053
| +44% | +$4.24M | 0.47% | 46 |
|
|
2023
Q3 | $9.92M | Sell |
66,571
-4,200
| -6% | -$617K | 0.36% | 62 |
|
|
2023
Q2 | $9.53M | Buy |
70,771
+3,428
| +5% | +$503K | 0.34% | 58 |
|
|
2023
Q1 | $10.7M | Buy |
67,343
+48,343
| +254% | +$7.39M | 0.45% | 48 |
|
|
2022
Q4 | $3.07M | Sell |
19,000
-42,413
| -69% | -$6.5M | 0.32% | 106 |
|
|
2022
Q3 | $8.24M | Sell |
61,413
-2
| -0% | -$287 | 0.39% | 66 |
|
|
2022
Q2 | $9.41M | Sell |
61,415
-9,928
| -14% | -$1.52M | 0.42% | 60 |
|
|
2022
Q1 | $11.6M | Buy |
71,343
+4,904
| +7% | +$712K | 0.43% | 48 |
|
|
2021
Q4 | $9M | Buy |
66,439
+3,615
| +6% | +$427K | 0.32% | 70 |
|
|
2021
Q3 | $6.78M | Sell |
62,824
-1,156
| -2% | -$132K | 0.26% | 89 |
|
|
2021
Q2 | $7.21M | Buy |
63,980
+9,313
| +17% | +$1.05M | 0.27% | 84 |
|
|
2021
Q1 | $5.92M | Buy |
54,667
+1,188
| +2% | +$127K | 0.21% | 108 |
|
|
2020
Q4 | $5.73M | Sell |
53,479
-68,662
| -56% | -$6.6M | 0.26% | 79 |
|
|
2020
Q3 | $10.7M | Buy |
122,141
+66,471
| +119% | +$6.26M | 0.44% | 44 |
|
|
2020
Q2 | $5.47M | Buy |
55,670
+1,686
| +3% | +$148K | 0.3% | 64 |
|
|
2020
Q1 | $4.11M | Buy |
53,984
+1,000
| +2% | +$85.2K | 0.3% | 69 |
|
|
2019
Q4 | $4.69M | Sell |
52,984
-50,182
| -49% | -$4.17M | 0.26% | 79 |
|
|
2019
Q3 | $7.81M | Sell |
103,166
-7,800
| -7% | -$535K | 0.46% | 51 |
|
|
2019
Q2 | $8.07M | Buy |
110,966
+98,606
| +798% | +$7.75M | 0.46% | 49 |
|
|
2019
Q1 | $153K | Sell |
12,360
-143,823
| -92% | -$11.8M | 0.6% | 27 |
|
|
2018
Q4 | $14.4M | Buy |
156,183
+300
| +0.2% | +$26.4K | 0.98% | 17 |
|
|
2018
Q3 | $14.7M | Buy |
155,883
+12,300
| +9% | +$1.17M | 0.84% | 22 |
|
|
2018
Q2 | $13.3M | Buy |
143,583
+18,400
| +15% | +$1.8M | 0.83% | 20 |
|
|
2018
Q1 | $11.8M | Sell |
125,183
-4,416
| -3% | -$485K | 0.78% | 24 |
|
|
2017
Q4 | $12.5M | Buy |
129,599
+1,800
| +1% | +$170K | 0.8% | 20 |
|
|
2017
Q3 | $11.4M | Buy |
127,799
+47,700
| +60% | +$3.63M | 0.77% | 21 |
|
|
2017
Q2 | $5.81M | Sell |
80,099
-10,800
| -12% | -$726K | 0.41% | 49 |
|
|
2017
Q1 | $5.92M | Sell |
90,899
-15,032
| -14% | -$945K | 0.41% | 46 |
|
|
2016
Q4 | $6.63M | Sell |
105,931
-4,250
| -4% | -$259K | 0.51% | 31 |
|
|
2016
Q3 | $6.95M | Sell |
110,181
-50,831
| -32% | -$3.29M | 0.58% | 26 |
|
|
2016
Q2 | $9.97M | Buy |
161,012
+9,307
| +6% | +$567K | 0.88% | 18 |
|
|
2016
Q1 | $8.66M | Sell |
151,705
-25,543
| -14% | -$1.42M | 0.78% | 21 |
|
|
2015
Q4 | $10.5M | Buy |
177,248
+15,159
| +9% | +$873K | 1.02% | 15 |
|
|
2015
Q3 | $8.82M | Buy |
162,089
+2,419
| +2% | +$157K | 0.97% | 15 |
|
|
2015
Q2 | $10.7M | Sell |
159,670
-42,276
| -21% | -$2.76M | 1.11% | 14 |
|
|
2015
Q1 | $11.8M | Buy |
201,946
+186
| +0.1% | +$11.2K | 1.28% | 8 |
|
|
2014
Q4 | $13.2M | Buy |
201,760
+3,400
| +2% | +$214K | 1.54% | 5 |
|
|
2014
Q3 | $11.5M | Buy |
198,360
+15,500
| +8% | +$861K | 1.54% | 5 |
|
|
2014
Q2 | $10.3M | Sell |
182,860
-1,728
| -0.9% | -$90.7K | 1.44% | 5 |
|
|
2014
Q1 | $9.49M | Buy |
184,588
+13
| +0% | +$657 | 1.39% | 4 |
|
|
2013
Q4 | $9.75M | Buy |
184,575
+14
| +0% | +$688 | 1.47% | 4 |
|
|
2013
Q3 | $8.26M | Buy |
184,561
+16
| +0% | +$709 | 1.38% | 6 |
|
|
2013
Q2 | $7.63M | Buy |
+184,545
| New | +$8.07M | 1.39% | 6 |
|
Other funds holding ABBV
VCM
VPM
Shelton Capital Management's ABBV Position: Q1 2026 in Review
Shelton Capital Management increased its AbbVie (ABBV) stake by 3.8% in Q1 2026, buying an estimated $397K and bringing the position to 49,244 shares worth $10.7M. The position accounts for 0.23% of the portfolio, ranked #97.
Shelton Capital Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $21.5M in Q2 2024. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Shelton Capital Management held 49,244 shares of AbbVie worth $10.7M as of Q1 2026.
- Shelton Capital Management bought 1,789 AbbVie shares in Q1 2026, an estimated $397K.
- AbbVie made up 0.23% of Shelton Capital Management's portfolio in Q1 2026, its #97 holding.
- Shelton Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Shelton Capital Management's AbbVie position peaked at $21.5M in Q2 2024.
- 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Shelton Capital Management's 13F filing for Q1 2026, filed 15 May 2026.